News

Article

PDA Publishes Technical Report on Drug Shortages

The Parenteral Drug Association report addresses prevention and communication of drug shortages caused by manufacturing and quality related disruptions.

The Parenteral Drug Association (PDA) has published Technical Report No. 68 (TR 68), Risk-Based Approach for Prevention and Management of Drug Shortages, which was developed from PDA's participation in a collaborative inter-association drug shortage team to develop solutions to address prevention and communication of drug shortages caused by manufacturing and quality related disruptions.

The report is the first practical approach to identifying and mitigating drug-shortage risks in a structured way, and once implemented, it could lead to fewer drug shortages, said PDA in a press release. The report was developed with input and support from the European Medicines Agency (EMA), several European Union National Competent Authorities (NCAs), and FDA. EMA and European inspectors will be promoting TR 68 in the European Union as best practice for proactively identifying and managing risks to supply caused by manufacturing and quality issues.  

Although causes of drug shortages are many, a high percentage are related to sterile injectable products, and a majority of these shortages in the US are caused by manufacturing and quality issues, notes PDA in the introduction to the report. The report addresses a risk-based framework for prevention and management of drug shortages caused by manufacturing and quality issues and explains a risk triage model to assess risks and implement appropriate controls. The report also includes templates for developing a Drug Shortage Risk Register and a Drug Shortage Prevention and Response Plan at a product level. The risk triage model and templates will also be made available from the EMA website. PDA will soon be launching training on this technical report including practical application and use of the risk triage model and templates.

Source: PDA

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More